Hyperguides

Plastic surgery / Plastic Surgery

Assessing Options for Postoperative Pain Management in Bariatric Surgery: Where We’ve Been….Where We’re Going

Stephanie B Jones, MD; Philip Schauer, MD; Alfonso Torquati, MD, MSCI, FACS
Course overview
 
 
Author(s)/Faculty: Stephanie B Jones, MD; Philip Schauer, MD; Alfonso Torquati, MD, MSCI, FACS
Type: Slides/Audio Lecture
Release Date: 12/15/2014 Expiration Date: 12/14/2015
Credit Type: CME/Participation Number of Credit(s): 1.5

by Philip Schauer, MD; Stephanie B Jones, MD; Alfonso Torquati, MD, MSCI, FACS

Support Statement: This activity is supported by an educational grant from Pacira Pharmaceuticals, Inc.

Target Audience: The intended audience for the activities is bariatric surgeons, obesity specialists and other health care professionals involved in the treatment of patients who are having or have had bariatric surgery.

Learning Objectives:
Upon successful completion of this educational activity, participants should be better able to:

  • Examine current postsurgical practice patterns in regard to pain management in patients who have undergone bariatric procedures.
  • Compare the use of longer-acting local anesthetics with shorter-acting local anesthetics and opioid drugs for postoperative pain in bariatric patients.
  • Assess bariatric patients for pain and use of opioid therapy prior to surgery to better select strategies that will meet their individual needs and improve postsurgical outcomes.
  • Evaluate the postoperative outcomes of bariatric patients who have received opioids, short-acting analgesics, and long-acting analgesics in terms of length of hospitalization, relief of comorbidities, and overall patient quality of life.

Activity Chair
Philip R. Schauer, MD
Chief of Minimally Invasive General Surgery and Director
Cleveland Clinic Bariatric and Metabolic Institute
Professor of Surgery
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Cleveland, OH

Faculty
Stephanie B. Jones, MD
Associate Professor of Anesthesia
Harvard Medical School
Vice Chair for Education
Department of Anesthesia
Critical Care and Pain Medicine
Beth Israel Deaconess Medical Center
Boston, MA

Alfonso Torquati, MD, MSCI, FACS
Associate Professor and Chief
Division of Metabolic and Weight Loss Surgery
Department of Surgery
Duke University
Durham, NC

Reviewers:
Jacob L. Hutchins, MD
Ronald Codario, MD, FACP, FNLA, CCMEP

This enduring material is approved for 1 year from the date of original release, December 15, 2014, to December 14, 2015.

Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.

The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.

Faculty members report the following relationship:
Stephanie B Jones, MD
No relevant financial relationships to disclose

Philip R. Schauer, MD
Consulting: Ethicon, Lilly, Novo Nordisk, Nestle
Contracted Research: National Institutes of Health
Salary: Springer, Inc. (Textbooks of Bariatric Surgery)
Board Memberships: Surgiquest

Alfonoso Torquiti, MD
Consulting Fees: Gore
Speakers Bureau: Cinemed

Reviewers report the following relationship(s):
Jacob Hutchins, MD
Consulting Fees: Pacira
Speakers Bureau: Pacira and I-Flow
Contracted Research: Pacira

Ronald Codario, MD, FACP, FNLA, CCMEP
No relevant financial relationships to disclose.

Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.